FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sandoz Fosinopril Sodium and Hydrochlorothiazide Recall

Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/12

Sandoz Inc · Wilson, NC

Risk level
Class II
Reported by FDA
Jan 8, 2014
Recall ID
D-393-2014
Check your lot numberHow we source this data

Summary

Sandoz recalled Fosinopril Sodium and Hydrochlorothiazide starting Oct 11, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-393-2014 on Jan 8, 2014. Reason: Subpotent; Hydrochlorothiazide at the 9 month time point. Status: Terminated.

Why it was recalled

Subpotent; Hydrochlorothiazide at the 9 month time point.

Product description

Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/12.5 mg, Rx Only, 100 Tablets, Sandoz Inc. Princeton, NJ 08540 ---NDC 0185-0341-01,

Lot numbers, UPCs & expiration codes

Lot CU0856

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-393-2014
Classification
Class II
Status
Terminated
Recall initiated
Oct 11, 2013
FDA report date
Jan 8, 2014
Quantity
2,491 bottles of 100 tablets each
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Inc

Original FDA data

Every field from FDA enforcement report D-393-2014, exactly as published.

Show all FDA fields
City
Wilson
State
NC
Status
Terminated
Country
United States
Event ID
66554
Address
4700 Sandoz Dr
Code information
Lot CU0856
Postal code
27893-8143
Report date
Jan 8, 2014
Product type
Drugs
Recall number
D-393-2014
Classification
Class II
Recalling firm
Sandoz Inc
Product quantity
2,491 bottles of 100 tablets each
Termination date
Mar 5, 2015
Reason for recall
Subpotent; Hydrochlorothiazide at the 9 month time point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/12.5 mg, Rx Only, 100 Tablets, Sandoz Inc. Princeton, NJ 08540 ---NDC 0185-0341-01,
Distribution pattern
Nationwide
Recall initiation date
Oct 11, 2013
Initial firm notification
Letter
Center classification date
Dec 30, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-393-2014, published Jan 8, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls